News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Immunobiology Limited (ImmBio) Strikes China Deal with China National Biotech Group Unit for TB Vaccine


11/4/2011 12:08:40 PM

November 4, 2011 -- ImmunoBiology Ltd (ImmBio), a Cambridge, UK vaccine company, has joined with Sinopharm Vaccine Institute, a part of CNBG (China National Biotech Group), to co-develop T-BioVax, ImmBio’s proprietary TB vaccine. The goal of the partnership is to bring the T-BioVax vaccine through SFDA approval and market it in China initially. More details....

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES